Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

NCT02500940 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2015-07-17

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of different neoadjuvant chemotherapy schedules of cisplatin and 5-FU on acute toxicity, tumor response, and long-term survival in patients with advanced nasopharyngeal carcinoma

Conditions

  • Nasopharyngeal Carcinoma

Interventions

DRUG

Cisplatin

Neoadjuvant chemotherapy regimen with cisplatin

DRUG

Fluorouracil

Neoadjuvant chemotherapy regimen with Fluorouracil

RADIATION

Radiation therapy

Intensity-Modulated Radiation Therapy

DRUG

Leucovorin

Neoadjuvant chemotherapy regimen with Leucovorin

Sponsors & Collaborators

  • Fujian Cancer Hospital

    collaborator OTHER_GOV
  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Lin Jin-Ching, Ph.D · Taichung Veterans General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-05-31
Completion
2021-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500940 on ClinicalTrials.gov